Are pharmacotherapeutics effective for treating aphasia?

Guadalupe DávilaMarcelo L. Berthiera Cognitive Neurology and Aphasia Unit,Centro de Investigaciones Médico-Sanitarias,University of Málaga,Málaga,Spainb Language Neuroscience Research Laboratory,Faculty of Psychology and Speech Therapy,University of Málaga,Málaga,Spainc Department of Psychobiology and Methodology of Behavioral Sciences,Faculty of Psychology and Speech Therapy,University of Málaga,Málaga,Spaind Instituto de Investigación Biomédica de Málaga (IBIMA) - Plataforma Bionand,Málaga,Spain
DOI: https://doi.org/10.1080/14737175.2024.2313557
IF: 4.287
2024-02-08
Expert Review of Neurotherapeutics
Abstract:Introduction Aphasia is a communication disorder resulting from stroke and/or neurodegenerative conditions which involve the left cerebral hemisphere. It is a debilitating disorder affecting a person's ability to speak, understand, read, and write. Its impact on daily life necessitates therapeutic strategies to aid patients with aphasia.
pharmacology & pharmacy,clinical neurology
What problem does this paper attempt to address?